AINDEX
Markets

Revelation Biosciences, Inc. (REVBW)

REVBWNASDAQ-CMBiotechnology: Pharmaceutical Preparations

$0.00210000

0.0000 (0.00%) today

Pre-market, Nov 19, 9:55 AM ET

No price history for this range
-38.24% 1D
Market cap
$1,435
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$0.00210000 to $0.0398
Average volume
–
Previous close
$0.00210000

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue––––
Gross profit––––
Operating income-$2.57m-$3.09m-$3.66m-$3.38m
Net income-$2.51m-$3.01m-$3.32m-$3.32m

News

8 latest

The company

Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on developing innovative therapies to restore balance to the body's inflammatory response. Through its proprietary Gemini therapeutic platform, Revelation is pursuing a differentiated approach to treating diseases driven by excessive or dysregulated inflammation. The Company's lead program targets acute kidney injury, a serious condition with significant unmet medical need and limited treatment options. Revelation believes Gemini's multimodal mechanism of action has the potential to support improved healing and recovery across a broad range of acute and chronic inflammatory diseases.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.